🩺 Hepatology · Gastroenterology

MELD Score Calculator

Updated 2026-06-09 Medically reviewed Medically reviewed
⚠️ For clinical decision support only — always apply professional judgement
MELD & MELD-Na Calculator
ℹ️ MELD uses floor values: Bilirubin, INR, and Creatinine minimum 1.0. Creatinine capped at 4.0 (patients on dialysis = 4.0).
mg/dL (min 1.0 applied)
International Normalised Ratio (min 1.0)
mg/dL (min 1.0, max 4.0, dialysis = 4.0)
mmol/L — range 125–137 used in MELD-Na
MELD Score
MELD-Na Score
90-day mortality estimate
MELD
score
MELD-Na
score
3-Month Mortality
%
📋 Contents — tap to expand
👨‍⚕️
Reviewed by Dr. Sharma, MBBS AFIH

Medical Officer, AAC Clinic · Updated 2026-06-09

1MELD Score — Mortality by Score

MELD Score3-Month MortalityTransplant Priority
< 9~1.9%Low — outpatient management
10–19~6%Moderate — transplant listing consideration
20–29~20%High — active transplant evaluation
30–39~53%Very High — urgent listing
≥ 40>71%Critical — highest priority (1A status)

MELD Formula

MELD = 3.78 × ln(Bilirubin) + 11.2 × ln(INR) + 9.57 × ln(Creatinine) + 6.43
Minimum values: Bili ≥1.0, INR ≥1.0, Cr ≥1.0, Cr max 4.0

MELD-Na = MELD − Na − (0.025 × MELD × (140 − Na)) + 140
Na range clamped to 125–137 mmol/L

MELD-Na vs MELD — Why Sodium Matters

Hyponatraemia in cirrhosis is a marker of advanced disease, portal hypertension, and activated renin-angiotensin-aldosterone system. Patients with the same MELD score but lower serum sodium have significantly higher 90-day waitlist mortality. The United Network for Organ Sharing (UNOS) adopted MELD-Na in January 2016, replacing MELD as the primary organ allocation score.

MELD-Na ranges from 6 to 40. A patient with MELD 20 and sodium 128 mmol/L has MELD-Na ≈ 25 — significantly higher priority for organ allocation than their MELD alone would suggest.

MELD 3.0 — The Newest Formula

MELD 3.0 was introduced in 2021 to address sex-based disparities in liver transplantation (women historically had lower access despite equivalent illness severity). MELD 3.0 adds serum albumin and a female sex coefficient: MELD 3.0 = 4.56 × ln(Bili) + 0.82 × (137 − Na) − 0.24 × (137 − Na) × ln(Cr) + 9.09 × ln(INR) + 11.14 × ln(Cr) + 1.85 × (3.5 − Alb) + 1.33 (if female) + 7. Some UNOS regions are transitioning to MELD 3.0.

Clinical Uses Beyond Transplantation

  • Surgical risk assessment: MELD predicts 30-day post-operative mortality in cirrhotic patients. MELD <10 = low risk (~4%). MELD 10–15 = moderate risk (~9%). MELD >15 = high risk (>25%). Elective surgery should generally be avoided if MELD >20
  • Acute alcoholic hepatitis: Maddrey Discriminant Function (MDF) is used alongside MELD. MELD >20 in alcoholic hepatitis predicts high mortality and may guide corticosteroid therapy decisions
  • Acute-on-chronic liver failure (ACLF): CLIF-C ACLF score has largely replaced MELD for short-term prognosis in ACLF, but MELD is still used for organ allocation
  • Variceal bleeding: MELD at admission predicts 6-week mortality after variceal haemorrhage

2Frequently asked questions

What is a dangerous MELD score?

A MELD score ≥15 indicates significant mortality risk and is the threshold for listing for liver transplantation in most centres. MELD 15–19 carries ~20% 3-month mortality without transplantation. MELD 20–29 carries 40–50% 3-month mortality. MELD ≥30 carries 70–80% 3-month mortality. MELD ≥40 has >90% 3-month mortality without transplantation.

What is the difference between MELD and MELD-Na?

MELD-Na adds serum sodium to the original MELD score because hyponatraemia is an independent predictor of mortality in cirrhosis not captured by the original MELD formula. MELD-Na = MELD − serum Na − (0.025 × MELD × (140 − serum Na)) + 140. UNOS adopted MELD-Na in 2016 for organ allocation. Patients with the same MELD but lower sodium have higher waitlist mortality — MELD-Na corrects for this.

📋
Key takeaway: Add a 2–3 sentence clinical summary here.

Medical disclaimer: This calculator is for educational and clinical decision-support purposes only. It does not replace clinical judgment or specialist consultation. RxMedCalc is not liable for clinical decisions made solely on this tool.